News from

Medicine

Reset All Filters
1691 Results
Standardizing provider assessments to aid veterans at risk of suicide
An Army veteran speaking with a medical professional.

Image: iStock/Drazen Zigic

Standardizing provider assessments to aid veterans at risk of suicide

A Penn Medicine study of nearly 39,000 health records is the first to examine access to firearms and opioids, and completion of related interventions, among veterans at risk for suicide receiving care at the VA.

Eric Horvath

The compassionate team behind CAR T cancer breakthroughs
From left, research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka in a hospital.

(From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.

(Image: Courtesy of Penn Medicine News)

The compassionate team behind CAR T cancer breakthroughs

The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside.

From Penn Medicine News

The motor driving Penn’s biomedical research
Michael Ostap

Michael Ostap is the interim senior vice dean and chief scientific officer of the Perelman School of Medicine.

(Image: Courtesy of Penn Medicine Magazine)

The motor driving Penn’s biomedical research

For nearly three decades, interim senior vice dean and chief scientific officer of the Perelman School of Medicine Michael Ostap has investigated how molecules such as myosin feel force, in an effort to understand how cellular mutations cause disease.

Meredith Lidard Kleeman for Penn Medicine Magazine

Science behind genetic testing for identifying risk of opioid misuse remains unproven
A scientist with a pipette and a test tube with a computer screen in the background.

Image: iStock/Cavan Images

Science behind genetic testing for identifying risk of opioid misuse remains unproven

A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.

Eric Horvath

Developing a tiny anticancer weapon
A cancer cell breaking up.

Image: iStock/Bahaa_Aladdin

Developing a tiny anticancer weapon

Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.
Penn Center for Innovation celebrates 10 years
Scientists holding a model of something (forthcoming)

(Image: Eric Sucar)

Penn Center for Innovation celebrates 10 years

The University’s nexus for technology transfer supports researchers in their innovative efforts, from CAR T to mRNA advancements that have dramatically reshaped the world.